HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chien-Hung Chen Selected Research

Tenofovir (Viread)

2/2022Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study.
1/2022Tenofovir Is Superior to Entecavir on Tertiary Prevention for BCLC Stage 0/A Hepatocellular Carcinoma after Curative Resection.
1/2022Predictors of Virological Suppression After Clinical Relapse in Patients Who Discontinued Entecavir or Tenofovir.
1/2022Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive Patients.
1/2022Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse.
12/2021Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.
4/2021A novel evidence of serial changes of bone mineral density in chronic hepatitis B patients treated with entecavir.
4/2021Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessation.
12/2020Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naïve patients with chronic hepatitis B-related compensated cirrhosis in Taiwan.
12/2020Associations of HBV Genotype B vs C Infection With Relapse After Cessation of Entecavir or Tenofovir Therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chien-Hung Chen Research Topics

Disease

81Hepatocellular Carcinoma (Hepatoma)
10/2022 - 03/2004
58Chronic Hepatitis B
02/2022 - 09/2004
54Fibrosis (Cirrhosis)
10/2022 - 03/2004
43Neoplasms (Cancer)
11/2022 - 09/2004
35Chronic Hepatitis C
03/2022 - 12/2002
34Infections
10/2022 - 12/2002
23Hepatitis B
10/2022 - 06/2002
12Hepatitis
12/2021 - 03/2002
11Hepatitis C
01/2021 - 12/2002
10Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 11/2003
8Disease Progression
01/2022 - 11/2005
6Liver Neoplasms (Liver Cancer)
01/2022 - 05/2005
6Diabetes Mellitus
01/2022 - 05/2011
6Liver Diseases (Liver Disease)
01/2020 - 10/2007
5Virus Diseases (Viral Diseases)
02/2022 - 05/2010
5Viremia
12/2021 - 04/2004
5Inflammation (Inflammations)
12/2021 - 11/2003
5Hypertension (High Blood Pressure)
01/2020 - 01/2013
5Breast Neoplasms (Breast Cancer)
01/2020 - 01/2010
5Carcinogenesis
01/2018 - 11/2005
4Chronic Renal Insufficiency
02/2022 - 01/2016
4Liver Failure
01/2018 - 06/2007
4Hemorrhage
07/2017 - 10/2004
4End Stage Liver Disease
06/2017 - 03/2014
4Insulin Resistance
01/2014 - 08/2009
3B-Cell Lymphoma (Lymphoma, B Cell)
12/2021 - 03/2010
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 07/2019
3Brain Neoplasms (Brain Tumor)
11/2019 - 09/2018
3Ascites
01/2015 - 06/2009
3Chronic Hepatitis (Chronic Active Hepatitis)
08/2014 - 05/2006
3Neoplasm Metastasis (Metastasis)
12/2013 - 05/2009
3Persistent Infection
06/2011 - 04/2008
3Necrosis
03/2010 - 03/2008
2Fatty Liver
12/2021 - 01/2013
2Lung Neoplasms (Lung Cancer)
11/2021 - 01/2010

Drug/Important Bio-Agent (IBA)

38Antiviral Agents (Antivirals)IBA
03/2022 - 10/2005
37entecavirFDA Link
02/2022 - 03/2012
32Hepatitis B Surface Antigens (HBsAg)FDA Link
10/2022 - 06/2002
28Hepatitis B e AntigensIBA
10/2022 - 03/2004
23Tenofovir (Viread)FDA Link
02/2022 - 01/2015
21InterferonsIBA
01/2021 - 12/2002
19Ribavirin (Virazole)FDA LinkGeneric
01/2021 - 12/2002
16DNA (Deoxyribonucleic Acid)IBA
11/2022 - 04/2004
15Alanine Transaminase (SGPT)IBA
12/2021 - 12/2002
13alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2022 - 11/2006
13AntigensIBA
01/2022 - 06/2002
13Lamivudine (Epivir)FDA Link
12/2017 - 03/2002
12AlbuminsIBA
04/2022 - 10/2007
11Proteins (Proteins, Gene)FDA Link
12/2021 - 09/2004
9BilirubinIBA
04/2022 - 11/2007
8Biomarkers (Surrogate Marker)IBA
11/2022 - 11/2005
7RNA (Ribonucleic Acid)IBA
11/2022 - 04/2004
7Fetal Proteins (Fetoprotein)IBA
01/2021 - 01/2013
6Sorafenib (BAY 43-9006)FDA Link
10/2021 - 12/2017
5Surface Antigens (Surface Antigen)IBA
11/2020 - 09/2007
4Transaminases (Aminotransferases)IBA
12/2021 - 05/2010
4Rituximab (Mabthera)FDA Link
12/2021 - 03/2010
4glecaprevir and pibrentasvirIBA
10/2020 - 08/2019
4TelbivudineFDA Link
07/2017 - 03/2012
4lipoarabinomannan (LAM)IBA
06/2014 - 01/2010
4adefovirIBA
02/2011 - 01/2006
4Serum AlbuminIBA
10/2007 - 10/2004
3VaccinesIBA
10/2022 - 09/2004
3SofosbuvirIBA
02/2022 - 01/2021
3Tyrosine Kinase InhibitorsIBA
11/2021 - 07/2019
3ErbB Receptors (EGF Receptor)IBA
11/2021 - 07/2019
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2018 - 01/2017
3CytokinesIBA
06/2016 - 08/2009
3MicroRNAs (MicroRNA)IBA
02/2016 - 01/2014
3EnzymesIBA
09/2015 - 03/2003
3Ethanol (Ethyl Alcohol)IBA
03/2010 - 05/2006
2sofosbuvir drug combination ledipasvirIBA
08/2022 - 01/2020
2Polysaccharides (Glycans)IBA
06/2022 - 10/2010
2Biological ProductsIBA
02/2022 - 08/2014
2AntibodiesIBA
12/2021 - 07/2012
2Caspase 3 (Caspase-3)IBA
11/2021 - 03/2008
2Immune Checkpoint InhibitorsIBA
10/2021 - 01/2021
2Formaldehyde (Formol)FDA Link
10/2021 - 12/2016
2ParaffinIBA
10/2021 - 12/2016
2Anti-Bacterial Agents (Antibiotics)IBA
05/2021 - 03/2008
2lenvatinibIBA
01/2021 - 01/2021
2ombitasvirIBA
01/2019 - 01/2019
2paritaprevirIBA
01/2019 - 01/2019
2Ritonavir (Norvir)FDA Link
01/2019 - 01/2019
2Pharmaceutical PreparationsIBA
01/2019 - 07/2011
2dasabuvirIBA
01/2019 - 01/2019
2Hemoglobins (Hemoglobin)IBA
11/2017 - 11/2006
2Folic Acid (Vitamin M)FDA LinkGeneric
01/2017 - 02/2014
2Calcitriol Receptors (Calcitriol Receptor)IBA
04/2016 - 08/2014

Therapy/Procedure

73Therapeutics
10/2022 - 12/2002
8Aftercare (After-Treatment)
01/2020 - 07/2010
7Radiofrequency Ablation
06/2022 - 03/2010
7Drug Therapy (Chemotherapy)
12/2021 - 09/2010
6Radiotherapy
01/2020 - 02/2012
6Liver Transplantation
01/2020 - 07/2005
3Retreatment
01/2022 - 01/2019
3Surgical Instruments (Clip)
06/2009 - 10/2004
2Hepatectomy
01/2022 - 10/2019
2Immunotherapy
10/2021 - 09/2004
2Duration of Therapy
01/2020 - 09/2014